Professors

 

Assoz.- Prof. Mag. Dr. Anna Weinzinger, Privatdoz.

room: 2D178

tel: +43 1 4277 55311

e-mail: anna.stary@univie.ac.at

more information

Anna Weinzinger (photo: Michael Bründl)

 Publications

Zeige Ergebnisse 21 - 40 von 66
Baburin I, Varkevisser R, Schramm A, Saxena P, Beyl S, Szkokan P et al. Dehydroevodiamine and hortiamine, alkaloids from the traditional Chinese herbal drug Evodia rutaecarpa, are I-Kr blockers with proarrhythmic effects in vitro and in vivo. Pharmacological Research. 2018 Mai;131:150-163. doi: 10.1016/j.phrs.2018.02.024

Cervenka R, Lukacs P, Gawali VS, Ke S, Koenig X, Rubi L et al. Distinct modulation of inactivation by a residue in the pore domain of voltage-gated Na+ channels: mechanistic insights from recent crystal structures. Scientific Reports. 2018 Jan 12;8(1):631. doi: 10.1038/s41598-017-18919-1

Gualdani R, Cavalluzzi MM, Tadini-Buoninsegni F, Convertino M, Gailly P, Stary-Weinzinger A et al. Molecular Insights into hERG Potassium Channel Blockade by Lubeluzole. Cellular Physiology and Biochemistry. 2018;45(6):2233-2245. doi: 10.1159/000488169

Gardner A, Wu W, Thomson S, Zangerl-Plessl E-M, Stary-Weinzinger A, Sanguinetti MC. Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3. Molecular Pharmacology. 2017 Okt;92(4):437-450. doi: 10.1124/mol.117.108886

Ji Y, Veldhuis MG, Zandvoort J, Romunde FL, Houtman MJC, Duran K et al. PA-6 inhibits inward rectifier currents carried by V93I and D172N gain-of-function KIR2.1 channels, but increases channel protein expression. Journal of Biomedical Science. 2017 Jul 15;24(1):44. 44. doi: 10.1186/s12929-017-0352-x

Saxena P, Zangerl-Plessl E-M, Linder T, Windisch A, Hohaus A, Timin E et al. New potential binding determinant for hERG channel inhibitors. Scientific Reports. 2016 Apr 12;6:24182. doi: 10.1038/srep24182

Linder T, Bernsteiner H, Saxena P, Bauer F, Erker T, Timin E et al. Drug trapping in hERG K+ channels: (Not) a matter of drug size? MedChemComm. 2016 Mär 1;7(3):512-518. doi: 10.1039/c5md00443h


Thurner P, Stary-Weinzinger A, Gafar H, Gawali VS, Kudlacek O, Zezula J et al. Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine. Journal of Pharmacology and Experimental Therapeutics. 2014 Feb;348(2):346-358. doi: 10.1124/jpet.113.209643

Saxena P, Linder T, Stary-Weinzinger A, IJzerman AP, Timin E, Ecker GF et al. Insights into Molecular Basis of hERG Inhibition by Studying a Library of Dofetilide Derivatives. Biophysical Journal. 2014 Jan 28;106(2):138a. doi: 10.1016/j.bpj.2013.11.806

Lukacs P, Gawali V, Cervenka R, Ke S, Rubi L, Zarrabi T et al. Exploring the structure of the voltage-gated Na+ channel by an engineered drug access pathway to the receptor site for local anesthetics. Journal of Biological Chemistry. 2014;289(31):21770-21781. doi: 10.1074/jbc.M113.541763

Takanari H, Nalos L, Stary-Weinzinger A, de Git KCG, Varkevisser R, Linder T et al. Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue. Cardiovascular Research. 2013 Jul 1;99(1):203-214. doi: 10.1093/cvr/cvt103

Zeige Ergebnisse 21 - 40 von 66

 Projects

Zeige Ergebnisse 1 - 4 von 4

PROSTAGLANDINES - POTENTIAL THERAPEUTICS FOR DEND SYNDROME?

Weinzinger, A.

1/12/2030/07/23

Projekt: Forschungsförderung


Sulfonylharnstoffe

Weinzinger, A.

1/03/1528/02/19

Projekt: Forschungsförderung


hERG K+ Channel activators

Weinzinger, A.

4/11/144/11/15

Projekt: Forschungsförderung


Molekulare Arzneistoff-Targets

Hering, S., Ecker, G., Maulide, N., Weinzinger, A. & Gonzalez Herrero, L.

1/12/1031/12/22

Projekt: Forschungsförderung


Zeige Ergebnisse 1 - 4 von 4